Breast MRI with Gadopiclenol

Presented by:
Katja Pinker-Domenig, MD, PhD, EBBI, FISMRM, FSBI

Accredited by The Association for Medical Imaging Management (AHRA) for 1.0 Category A ARRT and 1.0 AHRA CRA continuing education credits.

This educational program provides a clinical rationale for lowering the administered gadolinium dose when performing breast MRI on patients who may receive repeat MR contrasted exams throughout their lifetime for breast cancer screening. Through a review of case studies, Dr. Pinker-Domenig will provide insight on how to achieve optimal imaging while lowering the gadolinium dose with Gadopiclenol for breast MRI. Following the presentation, questions from the audience were addressed during a live Q&A session.

Clinical Applications of MR Imaging in Stereotactic Localization Radiosurgery Procedures

Presented by:
Glen Stevens, DO, PhD | Jenny WU, MD

Accredited by The Association for Medical Imaging Management (AHRA) for 1.5 Category A ARRT and CRA continuing education credits.

In this program, an experienced neuroradiologist and neuro oncologist will present their clinical experiences with the use of stereotactic localization radiosurgery, following the administration of a high relaxivity GBCA. Through case study examples, the clinical impact of contrast selection will be demonstrated. Following the presentation, questions from the audience were addressed during a live Q&A session.

Clinical Applications & Imaging Considerations of Gadopiclenol Injection

Presented by:
Lawrence N. Tanenbaum, MD, FACR | Applied Radiology

Accredited by The Association for Medical Imaging Management (AHRA) for 1.0 Category A ARRT and CRA continuing education credits.

In September 2022, Gadopiclenol injection, which is both macrocyclic (stable) and has high relaxivity properties received FDA marketing approval and may provide dosing options that can decrease gadolinium exposure, particularly in vulnerable patients.

In this accredited webinar, the assessment of Gadopiclenol injection in neuro, body, and pediatric MR imaging will be presented by a panel of MR imaging experts and will include commentary from Lawrence N. Tanenbaum, MD. To encourage audience participation, a live Q & A session will follow the discussion.